前往化源商城
入驻化源商城

醋酸氟轻松

更新时间:2024-01-02 11:21:14

醋酸氟轻松结构式
醋酸氟轻松结构式
品牌特惠专场
常用名 醋酸氟轻松 英文名 Fluocinolone Acetonide
CAS号 67-73-2 分子量 452.488
密度 1.4±0.1 g/cm3 沸点 578.5±50.0 °C at 760 mmHg
分子式 C24H30F2O6 熔点 267-269 °C(lit.)
MSDS 中文版 美版 闪点 303.7±30.1 °C
符号 GHS07
GHS07
信号词 Warning

 醋酸氟轻松用途


Fluocinolone Acetonide是糖皮质激素衍生物,可作用于各种皮肤病。

 醋酸氟轻松名称

中文名 醋酸氟轻松
英文名 fluocinolone acetonide
中文别名 醋酸肤轻松 | 肤轻松 | 氟轻松 | 仙乃乐 | 11b-羟基-16a,17-[(1-甲基亚乙基)-双(氧)]-21-(乙酰氧基)-6a,9-二氟孕甾-1,4-二烯-3,20-二酮 | 乙酸肤轻松
英文别名 更多

 醋酸氟轻松物理化学性质

密度 1.4±0.1 g/cm3
沸点 578.5±50.0 °C at 760 mmHg
熔点 267-269 °C(lit.)
分子式 C24H30F2O6
分子量 452.488
闪点 303.7±30.1 °C
精确质量 452.201050
PSA 93.06000
LogP 2.24
蒸汽压 0.0±3.6 mmHg at 25°C
折射率 1.577
储存条件 Refrigerator
分子结构

五、分子性质数据:

1、 摩尔折射率:109.50

2、 摩尔体积(m3/mol):330.3

3、 等张比容(90.2K):890.0

4、 表面张力(dyne/cm):52.7

5、 极化率(10-24cm3):43.41

计算化学

1.疏水参数计算参考值(XlogP):无

2.氢键供体数量:2

3.氢键受体数量:8

4.可旋转化学键数量:2

5.互变异构体数量:3

6.拓扑分子极性表面积93.1

7.重原子数量:32

8.表面电荷:0

9.复杂度:960

10.同位素原子数量:0

11.确定原子立构中心数量:9

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:1

更多

1. 性状:白色或近白色结晶性粉末,无味

2. 密度(g/mL,25/4℃):不确定

3. 相对蒸汽密度(g/mL,空气=1):不确定

4. 熔点(ºC):267-269 (lit.)

5. 沸点(ºC,常压):不确定

6. 沸点(ºC, 5.2kPa):不确定

7. 折射率:103 ° (C=1, MeOH)

8. 闪点(ºC):不确定

9. 比旋光度(º):不确定

10. 自燃点或引燃温度(ºC):不确定

11. 蒸气压(kPa,25ºC):不确定

12. 饱和蒸气压(kPa,60ºC):不确定

13. 燃烧热(KJ/mol):不确定

14. 临界温度(ºC):不确定

15. 临界压力(KPa):不确定

16. 油水(辛醇/水)分配系数的对数值:不确定

17. 爆炸上限(%,V/V):不确定

18. 爆炸下限(%,V/V):不确定

19. 溶解性:不溶于水,易溶于丙酮,在乙醇、氯仿中溶解,在乙醚中微溶

 醋酸氟轻松MSDS

 醋酸氟轻松毒性和生态

 醋酸氟轻松安全信息

符号 GHS07
GHS07
信号词 Warning
危害声明 H315-H319-H335
警示性声明 P261-P305 + P351 + P338
个人防护装备 dust mask type N95 (US);Eyeshields;Gloves
危害码 (欧洲) Xn:Harmful
风险声明 (欧洲) R20/21/22;R36/37/38;R40
安全声明 (欧洲) S26-S36-S22
危险品运输编码 NONH for all modes of transport
WGK德国 3
RTECS号 TU3830000
海关编码 2937210000

 醋酸氟轻松合成线路

~%

醋酸氟轻松结构式

醋酸氟轻松

67-73-2

文献:Journal of Labelled Compounds and Radiopharmaceuticals, , vol. 53, # 5-6 p. 260 - 265

~%

醋酸氟轻松结构式

醋酸氟轻松

67-73-2

文献:Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, , vol. 75, # 2 p. 930 - 935

~%

醋酸氟轻松结构式

醋酸氟轻松

67-73-2

文献:Journal of Labelled Compounds and Radiopharmaceuticals, , vol. 52, # 4 p. 103 - 109

~%

醋酸氟轻松结构式

醋酸氟轻松

67-73-2

文献:Molecules, , vol. 16, # 3 p. 2658 - 2671

~%

醋酸氟轻松结构式

醋酸氟轻松

67-73-2

文献:Molecules, , vol. 16, # 3 p. 2658 - 2671

~%

醋酸氟轻松结构式

醋酸氟轻松

67-73-2

文献:Molecules, , vol. 16, # 3 p. 2658 - 2671

~%

醋酸氟轻松结构式

醋酸氟轻松

67-73-2

文献:Molecules, , vol. 16, # 3 p. 2658 - 2671

~%

醋酸氟轻松结构式

醋酸氟轻松

67-73-2

文献:Molecules, , vol. 16, # 3 p. 2658 - 2671

 醋酸氟轻松海关

海关编码 2937210000

 醋酸氟轻松文献47

更多文献
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

J. Sci. Ind. Res. 65(10) , 808, (2006)

Drug-induced liver injury (DILI) is a significant concern in drug development due to the poor concordance between preclinical and clinical findings of liver toxicity. We hypothesized that the DILI typ...

Convenient QSAR model for predicting the complexation of structurally diverse compounds with β-cyclodextrins

Bioorg. Med. Chem. 17 , 896-904, (2009)

This paper reports a QSAR study for predicting the complexation of a large and heterogeneous variety of substances (233 organic compounds) with beta-cyclodextrins (beta-CDs). Several different theoret...

Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.

Bioorg. Med. Chem. 18 , 2225-31, (2010)

There are many of pathogen parasite species with different susceptibility profile to antiparasitic drugs. Unfortunately, almost QSAR models predict the biological activity of drugs against only one pa...

 醋酸氟轻松英文别名

(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-difluoro-5-hydroxy-6b-(hydroxyacétyl)-4a,6a,8,8-tétraméthyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodécahydro-2H-naphto[2',1':4,5]indéno[1,2-d][1,3]dioxol-2-one
(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-difluoro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
2H-Naphth[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, 4b,12-difluoro-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-5-hydroxy-6b-(2-hydroxyacetyl)-4a,6a,8,8-tetramethyl-, (4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-
EINECS 200-668-5
(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-difluoro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2
6a,9a-Difluoro-16a-hydroxyprednisolone 16,17-acetonide
MFCD00010525
(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-Difluor-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-
(6a,11b,16a)-6,9-Difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione
6a,9a-Difluoro-11b,16a,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone
6a,9a-Difluoro-16a,17a-isopropylidenedioxy-1,4-pregnadiene-3,20-dione
6α,9α-Difluoro-11β,16α,17α,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
Fluocinolone Acetonide
(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-Difluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
2H-naphth[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, 4b,12-difluoro-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-, (4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-
(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-Difluor-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-on
(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-difluoro-5-hydroxy-6b-(hydroxyacétyl)-4a,6a,8,8-tétraméthyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodécahydro-2H-naphto[2',1':4,5]indéno[1,2-d][1,3]dioxol-2-
Fluocinolone (Acetonide)
品牌现货直购
推荐供应商:







查看所有供应商和价格请点击:

醋酸氟轻松生产厂家

醋酸氟轻松价格